Neuropsychiatric complications from COVID-19
DOI:
https://doi.org/10.56294/saludcyt2022223Keywords:
Comorbidity, Confinement, COVID-19, Risk Factors, Neurobehavioral Manifestations, NeuropsychiatryAbstract
Introduction: COVID-19 manifests mainly as a respiratory disease, later with the course of the pandemic neurological symptoms were described, but mainly patients developed neurological complications, which manifested with neuropsychiatric symptoms in about 35,6 % of the cases with COVID-19 infection.
Aim: to determine neuropsychiatric complications due to COVID-19.
Method: a narrative review was carried out to gather information on neuropsychiatric complications due to COVID-19. For this purpose, indexed scientific articles published from 2020 to 2022, in Spanish and English, were consulted using scientific search engines such as PubMed and SciELO.
Results: the main neurological symptoms could be the consequence of multiorgan failure, severe infection or brainstem involvement. It has been reported that patients infected by SARS-CoV-2, after 3 weeks, developed altered mental status, encephalopathy, psychosis, neurocognitive syndrome (similar to dementia) and affective disorders. Persistent neurocognitive deficits were identified in patients with delirium even 18 months after discharge.
Conclusions: the effect of SARS-CoV-2 at the neuropsychiatric level is manifested as altered mental state, psychosis, depression, anxiety, neurocognitive syndrome, affective disorder, cognitive impairment, dementia, consciousness disorders. Thus, it is suggested that in the presence of risk factors such as critical patients or patients with encephalopathies, contact with persons with the infection should be prevented
References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine 2020;382:727-33. https://doi.org/10.1056/NEJMoa2001017.
2. Goodman-Casanova JM, Dura-Perez E, Guzman-Parra J, Cuesta-Vargas A, Mayoral-Cleries F. Telehealth Home Support During COVID-19 Confinement for Community-Dwelling Older Adults With Mild Cognitive Impairment or Mild Dementia: Survey Study. J Med Internet Res 2020;22:e19434. https://doi.org/10.2196/19434.
3. Chen Y, Yang W, Chen F, Cui L. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction. J Neuroinflammation 2022;19:222. https://doi.org/10.1186/s12974-022-02579-8.
4. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review. JAMA Neurol 2020;77:1018-27. https://doi.org/10.1001/jamaneurol.2020.2065.
5. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 2020;87:34-9. https://doi.org/10.1016/j.bbi.2020.04.027.
6. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18-22. https://doi.org/10.1016/j.bbi.2020.03.031.
7. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 2020;7:875-82. https://doi.org/10.1016/S2215-0366(20)30287-X.
8. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19. Neurology 2020;95:e1060-70. https://doi.org/10.1212/WNL.0000000000009937.
9. Tsai S-T, Lu M-K, San S, Tsai C-H. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol 2020;11:498. https://doi.org/10.3389/fneur.2020.00498.
10. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol 2020;19:767-83. https://doi.org/10.1016/S1474-4422(20)30221-0.
11. Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Kanti Ray B. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic. Can J Neurol Sci s. f.:1-16. https://doi.org/10.1017/cjn.2020.173.
12. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7:611-27. https://doi.org/10.1016/S2215-0366(20)30203-0.
13. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021;8:130-40. https://doi.org/10.1016/S2215-0366(20)30462-4.
14. Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1049-57. https://doi.org/10.15585/mmwr.mm6932a1.
15. Salluh JIF, Wang H, Schneider EB, Nagaraja N, Yenokyan G, Damluji A, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015;350:h2538. https://doi.org/10.1136/bmj.h2538.
16. Lara B, Carnes A, Dakterzada F, Benitez I, Piñol‐Ripoll G. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown. Eur J Neurol 2020;27:1744-7. https://doi.org/10.1111/ene.14339.
17. Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 2021:awab009. https://doi.org/10.1093/brain/awab009.
18. Epstein D, Andrawis W, Lipsky AM, Ziad HA, Matan M. Anxiety and Suicidality in a Hospitalized Patient with COVID-19 Infection. Eur J Case Rep Intern Med 2020;7:001651. https://doi.org/10.12890/2020_001651.
19. Bo H-X, Li W, Yang Y, Wang Y, Zhang Q, Cheung T, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med 2021;51:1052-3. https://doi.org/10.1017/S0033291720000999.
20. Parra A, Juanes A, Losada CP, Álvarez-Sesmero S, Santana VD, Martí I, et al. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Res 2020;291:113254. https://doi.org/10.1016/j.psychres.2020.113254.
21. Tariku M, Hajure M. Available Evidence and Ongoing Hypothesis on Corona Virus (COVID-19) and Psychosis: Is Corona Virus and Psychosis Related? A Narrative Review. Psychol Res Behav Manag 2020;13:701-4. https://doi.org/10.2147/PRBM.S264235.
22. Liu Y-H, Chen Y, Wang Q-H, Wang L-R, Jiang L, Yang Y, et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurology 2022;79:509-17. https://doi.org/10.1001/jamaneurol.2022.0461.
23. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open 2020;3:e203976. https://doi.org/10.1001/jamanetworkopen.2020.3976.
24. Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, et al. Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID‐19 pandemic, now and in the future. Alzheimers Dement 2020;16:1571-81. https://doi.org/10.1002/alz.12143.
25. Zhou J, Liu L, Xue P, Yang X, Tang X. Mental Health Response to the COVID-19 Outbreak in China. Am J Psychiatry 2020;177:574-5. https://doi.org/10.1176/appi.ajp.2020.20030304.
26. Carvalho PM de M, Moreira MM, de Oliveira MNA, Landim JMM, Neto MLR. The psychiatric impact of the novel coronavirus outbreak. Psychiatry Res 2020;286:112902. https://doi.org/10.1016/j.psychres.2020.112902.
Published
Issue
Section
License
Copyright (c) 2022 José Gabriel Gutiérrez Solano, Rosa Elizabeth Solornazo Bernita (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
